Grail was founded by gene sequencing company Illumina Inc in 2016, with investments from ARCH Venture Partners, Sutter Hill Ventures and Bezos Expeditions, the venture investment fund of Jeff Bezos.
The company, which is developing a blood test to identify early-stage cancers, has set a placeholder amount of $100 million for the IPO, without disclosing the size of its offering. Illumina is the majority shareholder in Grail with a 14.6% stake, according to the company’s filing with U.S. securities regulators.
Morgan Stanley, Goldman Sachs & Co LLC, and BofA Securities are acting as lead bookrunners for the proposed offering. The company has applied to list its stock on the Nasdaq under the ticker symbol “GRAL”. Reporting by Manas Mishra and Abhishek Manikandan in Bengaluru; Editing by Shounak Dasgupta and Shailesh Kuber
He has cancer duh!
why he doesn't invest in God and create a new human species? bro relax
BillGates is in Covid-19 JeffBezos is in cancer. . Do you see what i see fellow worldmen? We are sorrounded.
I think a bald tomhanks could play Jeff Bezos in a PrimeVideo movie nobody would watch.
JeffBezos' empire is about to crumble. Mark my words.
This guy is so greedy, now he wants to profit off of cancer patients.
The King and I Besos is really King - thanks to taxpayers bailing out the USPS again
Cancer testing... Why not cancer curing? Ah, there's more money in treating than test.
Omega watch and hermes tie🥶
Call me when you write an article about anti trust laws going after Bezos
what does this mean
Pretty good.
dunno, so much a lot of hype...